215 related articles for article (PubMed ID: 9093638)
1. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments.
Boussinesq M; Prod'hon J; Chippaux JP
Trans R Soc Trop Med Hyg; 1997; 91(1):82-6. PubMed ID: 9093638
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
[TBL] [Abstract][Full Text] [Related]
3. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
4. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
5. Impact of four years of large-scale ivermectin treatment with low therapeutic coverage on the transmission of Onchocerca volvulus in the Mbam valley focus, central Cameroon.
Pion SD; Clément MC; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Sep; 98(9):520-8. PubMed ID: 15251400
[TBL] [Abstract][Full Text] [Related]
6. [Long-term effect of a single dose of ivermectin on skin microfilarial density in an endemic onchocerciasis area of North Cameroon].
Boussinesq M; Prod'hon J; Chippaux JP; Quillévéré D
Ann Soc Belg Med Trop; 1993 Sep; 73(3):189-96. PubMed ID: 8279866
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico.
Rodríguez-Pérez MA; Danis-Lozano R; Rodríguez MH; Bradley JE
Trop Med Int Health; 1999 Feb; 4(2):98-104. PubMed ID: 10206263
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
9. Onchocerciasis in the Cameroon-Chad border area after more than 20 years of annual mass ivermectin distribution.
Ayisi F; de Souza DK; Tallant J; Biholong BD; Fokam EB; Boakye DA
Parasit Vectors; 2024 May; 17(1):219. PubMed ID: 38741212
[TBL] [Abstract][Full Text] [Related]
10. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
11. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
[TBL] [Abstract][Full Text] [Related]
12. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
Eisenbarth A; Achukwi MD; Renz A
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004392. PubMed ID: 26926855
[TBL] [Abstract][Full Text] [Related]
13. Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum.
Hendy A; Krit M; Pfarr K; Laemmer C; De Witte J; Nwane P; Kamgno J; Nana-Djeunga HC; Boussinesq M; Dujardin JC; Post R; Colebunders R; O'Neill S; Enyong P; Njamnshi AK
Parasit Vectors; 2021 Nov; 14(1):563. PubMed ID: 34727965
[TBL] [Abstract][Full Text] [Related]
14. Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.
Aza'ah RA; Sumo L; Ntonifor NH; Bopda J; Bamou RH; Nana-Djeunga HC
Parasit Vectors; 2020 Oct; 13(1):519. PubMed ID: 33066826
[TBL] [Abstract][Full Text] [Related]
15. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
[TBL] [Abstract][Full Text] [Related]
16. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
Katabarwa MN; Eyamba A; Nwane P; Enyong P; Yaya S; Baldiagaï J; Madi TK; Yougouda A; Andze GO; Richards FO
Am J Trop Med Hyg; 2011 Dec; 85(6):1041-9. PubMed ID: 22144441
[TBL] [Abstract][Full Text] [Related]
17. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.
Abong RA; Amambo GN; Chounna Ndongmo PW; Njouendou AJ; Ritter M; Beng AA; Esum ME; Deribe K; Fru-Cho J; Fombad FF; Nji TM; Enyong PI; Poole CB; Pfarr K; Hoerauf A; Carlow CKS; Wanji S
BMC Infect Dis; 2020 Oct; 20(1):726. PubMed ID: 33008333
[TBL] [Abstract][Full Text] [Related]
19. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
20. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
